Physician profile
Robin Heese
NPI 1578243358
$7,623.98
in general payments reported to CMS, 2019-2025
32 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,362 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,231 · Travel and Lodging: $2,896 · Education: $325 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122 · Gift: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,231.16 |
| Travel and Lodging | $2,895.86 |
| Education | $324.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122.05 |
| Gift | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,097.25 | 2024 | Interstim |
| Axonics, INC. | $1,597.81 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $585.12 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $513.11 | 2024-2025 | Erleada, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $314.32 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $305.28 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $302.75 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $200.38 | 2024-2025 | Lynparza |
| Endo USA, INC. | $163.57 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $140.15 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $118.95 | 2024-2025 | Keytruda |
| Teleflex LLC | $114.21 | 2025 | Barrigel |
| Astellas Pharma US INC | $99.99 | 2024 | |
| Valencia Technologies Corporation | $98.28 | 2025 | Ecoin Device Kit |
| Progenics Pharmaceuticals, INC. | $86.50 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $84.99 | 2025 | |
| Abbvie INC. | $82.00 | 2024-2025 | |
| Tolmar, INC. | $71.99 | 2024-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $70.37 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $68.31 | 2024-2025 | Magic3 Go Intermittent Urinary Catheter |
| Novo Nordisk INC | $67.29 | 2024 | Rivfloza |
| Sun Pharmaceutical Industries INC. | $66.88 | 2024 | |
| Tempus Ai, INC | $66.18 | 2025 | Xt Cdx |
| Novartis Pharmaceuticals Corporation | $66.14 | 2024-2025 | |
| Immunitybio, INC. | $65.91 | 2024 | |
| Boston Scientific Corporation | $57.78 | 2024-2025 | Ams 700 |
| Exelixis INC. | $34.61 | 2025 | Cabometyx |
| Blue Earth Diagnostics | $27.37 | 2025 | Posluma |
| Bioprotect Medical, INC. | $18.68 | 2025 | Bioprotect Balloon Implant System |
| 180 Medical, INC. | $15.00 | 2025 | |
| Endo Pharmaceuticals INC. | $14.86 | 2024 | Aveed, Xiaflex |
| Janssen Scientific Affairs, LLC | $7.95 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Heese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.